Oxford University's DrugGPT, an AI tool to tackle prescription issues, could revolutionize healthcare, preventing mistakes, improving compliance, and reducing expenses.
Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...